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Ectopic lymphoid structures (ELS) consist of B-cell and T-cell aggregates that are
initiated de novo in inflamed tissues outside of secondary lymphoid organs. When
organized within follicular dendritic cell (FDC) networks, ELS contain functional germinal
centers that can yield autoantibody-secreting plasma cells and promote autoimmune
disease. Intranasal instillation of lupus-prone mice with crystalline silica (cSiO2), a
respirable particle linked to human lupus, triggers ELS formation in the lung, systemic
autoantibodies, and early onset of glomerulonephritis. Here we tested the hypothesis
that consumption of docosahexaenoic acid (DHA), an ω-3 polyunsaturated fatty acid
with anti-inflammatory properties, influences the temporal profile of cSiO2-induced
pulmonary ectopic germinal center formation and development of glomerulonephritis.
Female NZBWF1 mice (6-wk old) were fed purified isocaloric diets supplemented with
0, 4, or 10 g/kg DHA - calorically equivalent to 0, 2, or 5 g DHA per day consumption
by humans, respectively. Beginning at age 8 wk, mice were intranasally instilled with
1mg cSiO2, or saline vehicle alone, once per wk, for 4 wk. Cohorts were sacrificed
1, 5, 9, or 13 wk post-instillation (PI) of the last cSiO2 dose, and lung and kidney
lesions were investigated by histopathology. Tissue fatty acid analyses confirmed uniform
dose-dependent DHA incorporation across all cohorts. As early as 1 wk PI, inflammation
comprising of B (CD45R+) and T (CD3+) cell accumulation was observed in lungs of
cSiO2-treated mice compared to vehicle controls; these responses intensified over time.
Marked follicular dendritic cell (FDC; CD21+/CD35+) networking appeared at 9 and 13
wk PI. IgG+ plasma cells suggestive of mature germinal centers were evident at 13 wk.
Bates et al. DHA Suppresses Ectopic Lymphoid Neogenesis
DHA supplementation dramatically suppressed cSiO2-triggered B-cell, T-cell, FDC, and
IgG+ plasma cell appearance in the lungs as well as anti-dsDNA IgG in bronchial lavage
fluid and plasma over the course of the experiment. cSiO2 induced glomerulonephritis
with concomitant B-cell accumulation in the renal cortex at 13 wk PI but this response
was abrogated by DHA feeding. Taken together, realistic dietary DHA supplementation
prevented initiation and/or progression of ectopic lymphoid neogenesis, germinal center
development, systemic autoantibody elevation, and resultant glomerulonephritis in this
unique preclinical model of environment-triggered lupus.
Keywords: autoimmunity, ectopic lymphoid structure, omega-3, polyunsaturated fatty acid, systemic lupus
erythematosus, silica, lung
INTRODUCTION
Systemic lupus erythematosus (lupus) is a heterogeneous
autoimmune disease (AD) that primarily affects young women
causing great individual suffering and social costs (1, 2).
Induction and progression of this disease is coordinated
by aberrant activation of innate and adaptive immunity.
Pathogenesis involves loss of tolerance to self-antigens, activation
of autoreactive B- and T-cells and consequent production of
pathogenic autoantibodies (3). The latter complex with self-
antigens such as dsDNA, forming circulating immune complexes
that amass within tissues. In the kidney, these complexes
drive mononuclear cell infiltration and activation, promoting
glomerulonephritis that often culminates in end-stage renal
disease (4).
During unresolved inflammation, ectopic lymphoid structures
(ELS) are induced to remediate high concentrations of locally-
present antigens in inflamed tissue and, thus, do not occur in
pre-programmed locations in the body. Also known as tertiary
lymphoid organs, ELS operate much like secondary lymphoid
organs; they serve structurally and functionally as a site for
antigen accumulation, presentation, and proliferation/activation
of B- and T-cells. B- and T-cell-rich areas are distinct with
the former being supported within a matrix of follicular
dendritic cells (FDCs) (5–7). Unlike hematopoietic myeloid and
plasmacytoid dendritic cells, FDCs are considered mesenchymal
in nature. They express low levels of major histocompatibility
complex (MHC) II and are identified by their surface expression
of FcγRIIb, complement receptor (CR) 1 (CD35), and CR2
(CD21) [reviewed in (8)]. These receptors facilitate FDC
presentation of immune complexes of antibody or complement-
opsonized antigens. FDCs dictate the fate of B-cells in germinal
centers by serving as a platform for their recruiting, activation,
differentiation, and survival (9). Importantly, ELS are frequently
associated with lupus and other ADs reflecting the intimate
Abbreviations: AD, autoimmune disease; ARA, arachidonic acid; BALF,
bronchoalveolar lavage fluid; cSiO2, crystalline silica; CON, control; DHA,
docosahexaenoic acid; ELS, ectopic lymphoid structure; EPA, eicosapentaenoic
acid; FA, fatty acid; FDC, follicular dendritic cell; HRP, horseradish peroxidase;
GLC, gas liquid chromatography; LA, linoleic acid; PBS, phosphate buffered saline;
PI, post-instillation; PUFA, polyunsaturated fatty acid; RT, room temperature;
SPMs, specific pro-resolving metabolite; VEH, vehicle.
association between aberrant inflammation and loss of self-
tolerance. ELS are found in AD target tissues such as kidneys
(lupus), salivary glands (Sjögren’s syndrome), and synovial joints
(rheumatoid arthritis) and correlate with disease severity (6, 10–
14).
Although lupus and other ADs are driven by an individual’s
genome, environmental factors such as toxicants and diet can
influence onset and severity of autoimmunity (15–20). Regarding
toxicants, it is well-established that inhaled crystalline silica dust
(cSiO2, quartz) can contribute to AD onset and progression
[reviewed in (21)]. Approximately 2.3 million individuals
who work in occupations such as mining, construction,
manufacturing, and farming are exposed to respirable cSiO2 (22).
Airway exposure to cSiO2 evokes overt and chronic inflammation
that affects not only the lung, but also distal organs by way
of systemic inflammation (23, 24). Epidemiological studies have
linked cSiO2 exposure to lupus, rheumatoid arthritis, Sjögren’s
syndrome, scleroderma, and systemic vasculitis (25–29).
Animal studies provide mechanistic insight into how cSiO2
might trigger autoimmunity in humans (30–33). Intranasal
cSiO2 instillation of the female NZBWF1 mouse, a widely used
murine model of human lupus (34), induces autoimmunity
and glomerulonephritis 3 months earlier than vehicle-instilled
controls (35). Concurrently, there are massive inflammatory
responses in the lungs as evidenced by intense perivascular
and peribronchial lymphocytic cell infiltration. These infiltrates
contain many B (CD45R+) cells and T (CD3+) cells indicative
of ectopic lymphoid neogenesis. Consistent with pulmonary
inflammation and ELS formation, bronchoalveolar lavage
fluid (BALF) from cSiO2-exposed mice contain elevated
concentrations of IgG, autoantibodies, chemokines, and
cytokines. These responses are similarly reflected in the
plasma and, therefore, indicative of parallel exacerbation of
systemic autoimmunity. Overall, these findings strongly indicate
that the lung acts as a platform for autoimmune triggering
by cSiO2.
Dietary intake of polyunsaturated fatty acids (PUFAs) may
have considerable influence on inflammation and autoimmunity
[reviewed in (36)]. PUFAs that have two or more double bonds
are designated as ω-3 or ω-6 based on the position of the first
double bond relative to the aliphatic chain’s terminal carbon.
Generally, ω-3 PUFAs are recognized to be anti-inflammatory
in nature, whereas ω-6 PUFAs are regarded as proinflammatory
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(37). Linoleic acid (C18:2 ω-6; LA), the most common PUFA in
the Western diet, is present in food oils produced from plants
such as corn and soybeans. After consumption by ruminants
and humans, LA can be elongated and desaturated enzymatically
to arachidonic acid (C20:4 ω-6; ARA). Thus, LA and ARA
are major components of cell membrane phospholipids. Even
though the ω-3 PUFA α-linolenic acid (C18:3 ω-3; ALA) is
additionally present in plant oils, humans and other mammals
have limited ability to elongate it enzymatically to more anti-
inflammatory forms, docosahexaenoic acid (C22:6 ω-3; DHA)
and eicosapentaenoic acid (C20:5 ω-3; EPA). Therefore, humans
need to obtain these PUFAs from exogenous sources. Several
marine algae proficiently catalyze formation of DHA and
EPA, and cold-water fish consuming these algae efficiently
bioconcentrate these PUFAs into their tissues (38). Accordingly,
fish, fish oil, and microalgal oil are significant sources of DHA
and EPA in the human diet (39).
Numerous preclinical investigations have demonstrated
that ω-3 PUFA-rich fish oil supplementation both prevents
and resolves inflammation [reviewed in (40, 41)]. Therefore,
its consumption might also benefit people with a genetic
predisposition to AD. In support of this contention,
fish oil supplementation of lupus-prone mice prevents
or delays glomerulonephritis and death from kidney
failure, with DHA-enriched fish oil having the greatest
potency (42–50). In a prior work, we compared latency
and severity of autoimmunity in female NZBWF1 mice
consuming (1) an ω-3 PUFA-rich diet containing DHA-
enriched fish oil, (2) an ω-6 PUFA-rich Western-type diet
containing corn oil, or (3) an ω-9 monounsaturated fatty
acid (MUFA)-rich Mediterranean-type diet containing
high oleic safflower oil (51). While increases of plasma
autoantibodies, proteinuria, and glomerulonephritis were
readily evident in mice consuming ω-6 PUFA or ω-9
MUFA diets, these outcomes were remarkably lessened in
animals fed the DHA-rich diet. These inhibitory effects
correlated with downregulation of genes associated with
inflammatory responses, antigen presentation, T-cell activation,
B-cell activation/differentiation and leukocyte recruitment.
Importantly, a large number of these genes are specific targets
for lupus intervention.
Recently, we queried how DHA supplementation influences
cSiO2-induced autoimmunity in female NZBWF1 mice. Dietary
DHA at concentrations that were calorically equivalent to 2,
6, and 12 g per day human consumption dose-dependently
suppressed cSiO2-triggered inflammation, accumulation of
pulmonary B- and T-cell aggregates, autoimmunity, and
glomerulonephritis (52). While these observations offer the
intriguing possibility that DHA supplementation could be used
to block environment-triggered lupus, such an interpretation
is constrained because the investigation focused only on
a single time point−3 months following the final cSiO2
instillation and after glomerulonephritis onset. Furthermore,
the presence of B- and T-cell aggregates was not explicitly
linked to the presence of FDCs and plasma cells. To address
these knowledge gaps, in the present study we determined
how dietary DHA supplementation, at two concentrations
that realistically mimic safe human consumption (2 and
5 g per day), influences the temporal profile of cSiO2-
triggered (1) pulmonary B-cells, T-cells, FDCs, and plasma
cells indicative of ectopic germinal centers, (2) systemic




All experimental protocols were reviewed and approved by the
Institutional Animal Care and Use Committee at Michigan State
University in accordance with the National Institutes of Health
guidelines (AUF #01/15-021-00). Female 6-wk-old lupus-prone
NZBWF1 mice were obtained from The Jackson Laboratories
(Bar Harbor, ME), housed four per cage with free access to
food and water, and kept at constant temperature (21–24◦C) and
humidity (40–55%) under a 12 h light/dark cycle.
Upon arrival and for the duration of the study, mice were
fed one of four experimental diets (Table 1). Formulations were
based on the semi-purified American Institute of Nutrition
(AIN)-93G containing 70 g/kg fat (53). To provide basal essential
fatty acids (FAs), all diets contained 10 g/kg corn oil. Control
diet (CON) was formulated with 60 g/kg high-oleic safflower
oil (Hain Pure Food, Boulder, CO). To prepare DHA-enriched
diets, high-oleic safflower oil was substituted with 10 g/kg (Low
DHA) or 25 g/kg (High DHA) microalgal oil containing 40%
DHA (DHASCO, kindly provided by Dr. Kevin Hadley, DSM
Nutritional Products, Columbia MD). This yielded experimental
diets that contained 4 or 10 g/kg DHA, respectively, andmodeled,
TABLE 1 | Diet formulations.
CON Low DHAe High DHAf
Casein 200 200 200
Dyetrose 132 132 132
Cornstarch 397.5 397.5 397.5
Sucrose 100 100 100
Cellulose 50 50 50
t-Butylhydroquinone (TBHQ) 0.01 0.01 0.01
AIN 93G Salt Mix 35 35 35
AIN 93G Vitamin Mix (with Vitamin E) 10 10 10
L-cysteine 3 3 3
Choline Bitartrate 2.5 2.5 2.5
Corn Oila,b 10 10 10
High-oleic safflower Oila,c 60 50 35
DHA-Enriched Algal Oila,d – 10 25
Values shown are the mass amounts (g) per kg diet.
a Based on oil composition reported by the manufacturer.
b Corn oil contained 612 g/kg linoleic acid and 26 g/kg oleic acid.
c High-oleic safflower oil contained 750 g/kg oleic acid and 140 g/kg linoleic acid.
d Algal oil contained 395 g DHA/kg and 215 g oleic acid/kg.
e 4 g/kg diet, calorically equivalent to human DHA consumption of 2 g/day.
f 10 g/kg diet, calorically equivalent to human DHA consumption of 5 g/day.
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on a caloric basis, humanDHA consumption of 2 and 5 g per day,
respectively.
Experimental Design
The experimental design for this study is depicted in Figure 1. At
6 wk of age, groups of mice (n= 8) were fed CON, Low DHA, or
High DHA diets and maintained on assigned diets until the end
of the experiment. To prevent the formation of lipid oxidation
products, diets were mixed weekly and stored at −20◦C until
use. Fresh feed was provided ad lib to mice daily. At 8 wk of
age, mice were anesthetized with 4% isoflurane and intranasally
instilled with 1mg cSiO2 in 25µl phosphate buffered saline (PBS)
or the PBS vehicle (VEH). Exposures were repeated once per
wk for 4 wk. cSiO2 (Min-U-Sil-5, 1.5–2.0µm average particle
size, Pennsylvania Sand Glass Corporation, Pittsburgh, PA) was
acid washed and dried prior to preparation of stock suspensions
of cSiO2 in VEH. Stock suspensions were prepared fresh in
VEH prior to exposure, sonicated, and vortexed rapidly for
1min prior to intranasal instillation. This dosing regimen reflects
approximately one half of a human lifetime exposure at the
recommended Occupational Safety and Health Administration
limit (35).
Cohorts of mice representing the four treatment groups
(i.e., CON/VEH, CON/cSiO2, Low DHA/cSiO2, and High
DHA/cSiO2) were sacrificed at 1, 5, 9, and 13 wk after the
final cSiO2 instillation. Mice were 12, 16, 20, and 24 wk of
age, respectively, at these time points. These time periods were
selected to capture pulmonary pathological changes in lupus-
prone NZBWF1 mice following cSiO2 exposure prior to and
during onset of glomerulonephritis based on prior studies (35,
52). Animals were euthanized by intraperitoneal injection with
56 mg/kg body weight sodium pentobarbital and exsanguination
via the abdominal aorta. Blood was collected with heparin-
coated syringes and centrifuged at 3500 × g for 10min at
4◦C for separation of erythrocytes and plasma which were
stored at −80◦C. BALF was collected from whole lungs as
described previously (54). After lavage, the right lung lobes were
removed, frozen in liquid nitrogen, and stored at−80◦C for FDC
immunohistochemistry. The left lung lobe was fixed with 10%
neutral buffered formalin (Fisher Scientific, Pittsburgh, PA) at
constant pressure (30 cm H2O) for minimum of 1 h and stored
in fixative until further processing for histology. The right kidney
was excised and the cranial portion fixed in 10% neutral buffered
formalin for 24 h.
Fatty Acid Analyses
Fatty acid (FA) concentrations in diets were determined by gas
liquid chromatography (GLC) as previously described (52). FA
data are reported as percentages (w/w) of FAs detected with a
chain length between 10 and 24 carbon atoms. The lower limit
of detection was <0.001 g/100 g fatty acids. FA concentrations in
erythrocytes were analyzed by GLC at Omega Quant (Sioux Falls,
SD).
BALF Cell Counts
Total cells in BALF were determined by counting on
a hemocytometer. Cytological slides were prepared by
centrifugation of 150 µl BALF for 10min at 400 × g, air-
drying, and staining with Diff-Quick (Thermo-Fisher).
Two hundred (200) cells were counted and designated as
monocytes/macrophages, lymphocytes, and eosinophils using
morphological criteria.
Anti-dsDNA IgG Analysis
Anti-dsDNA IgG responses in BALF and plasma were measured
using mouse anti-dsDNA IgG-specific ELISA Kit (Alpha
Diagnostic International, San Antonio, TX) according to
manufacturer’s instructions. Briefly, samples as well as standards
were added to plate wells, incubated and bound antibody was
FIGURE 1 | Experimental design. Feeding of groups of female NZBWF1 mice with CON (0 g/kg DHA), Low DHA (4 g/kg DHA) or High DHA (10 g/kg DHA) diets were
initiated at age 6 wk. At age 8 wk, mice were dosed intranasally with 25 µl PBS VEH or 25 µl PBS containing 1mg cSiO2 weekly for 4 wk. Cohorts (n = 7–8 per
group) of animals were terminated at 12, 16, 20, and 24 wk of age which corresponded to 1, 5, 9, and 13 wk post-instillation (PI) of final cSiO2 dose.
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measured using horseradish peroxidase (HRP)-labeled anti-
mouse IgG. Anti-dsDNA in samples was determined from
standard curve generated with mouse anti-dsDNA.
Histopathology of Lungs and Kidneys
Randomly oriented, serial sections of formalin-fixed left lung
lobes were processed routinely and embedded in paraffin.
Tissue sections (5µm) were deparaffinized and stained with
hematoxylin and eosin (H&E) for histopathology. Tissues
were scored semi-quantitatively in a blinded fashion by
a board-certified veterinary pathologist for the following
lung lesions: (a) presence of lymphoid aggregates within
perivascular and peribronchiolar regions; (b) histologically
evident ectopic lymphoid tissues; (c) presence of alveolar
proteinosis; (d) alveolitis defined as the increased accumulation
in the alveolar parenchyma of neutrophils, lymphocytes, and
mononuclear/macrophages; (e) alveolar type II epithelial cell
hyperplasia; and (f) mucous cell metaplasia in bronchiolar
epithelium. Individual lungs were graded for these lesions using
the following criteria (% of total pulmonary tissue examined): (0)
no changes compared to control mice; (1) minimal (<10%); (2)
slight (10–25%); (3) moderate (26–50%); (4) severe (51–75%); or
(5) very severe (>75%) of total area affected.
Formalin-fixed kidneys were randomly sectioned, paraffin-
embedded, cut and stained with either H&E or Periodic acid-
Schiff and hematoxylin (PASH). Stained sections were evaluated
for lupus nephritis by a board-certified veterinary pathologist
using a modified International Society of Nephrology/Renal
Pathology (ISN/RPS) Lupus Nephritis Classification system
(55). Slide sections were graded as follows: (0) no tubular
proteinosis and normal glomeruli; (1) mild tubular proteinosis
with multifocal segmental proliferative glomerulonephritis and
occasional early glomerular sclerosis and crescent formation; (2)
moderate tubular proteinosis with diffuse segmental proliferative
glomerulonephritis, early glomerular sclerosis and crescent
formation; and (3) marked tubular proteinosis with diffuse global
proliferative and sclerosing glomerulonephritis. The extent of
tubular necrosis was measured in PASH-stained slides by
morphometry as described below.
Immunohistochemistry of Lungs and
Kidneys
Immunohistochemistry was performed on formalin-fixed,
paraffin embedded, left lung lobe and right kidney for
identification of CD45R+ (B-cells). Sections were cut at
7µm on a microtome and placed on slides coated with 2%
3-aminopropyltriethoxysilane and dried at 56◦C overnight.
Slides were deparaffinized in xylene and rehydrated through
descending grades of ethyl alcohol to distilled water followed by
Tris Buffered Saline (TBS) (pH 7.4) without surfactant (Scytek
Labs, Logan, UT) for 5min for pH adjustment. Following
TBS treatment, paraffin-embedded tissue sections underwent
heat induced epitope recovery with Citrate Plus Retrieval pH
6.0 (Scytek Labs) for 30 mins at 125◦C followed by a 30min
incubation at room temperature (RT). Endogenous peroxidase
was blocked with 3% hydrogen peroxide and methanol (1:4) for
30min followed by tap and distilled water rinses.
After pretreatments, standard micro-polymer complex
staining was performed at RT on an IntelliPath Flex Autostainer
(Biocare Medical, Pacheco, CA). All staining steps were followed
by rinses in TBS autowash buffer (Biocare). After blocking for
non-specific protein with Rodent Block M (Biocare) for 20min,
sections were incubated with 1:600 rat anti-CD45R monoclonal
antibody (Becton Dickinson, Franklin Lakes, NJ; catalog #
550286) in normal antibody diluent (Scytek) for 1 h to identify
B-cells. Bound CD45R antibody was detected with ProMark
Rat-on-Mouse HRP Polymer by 30min incubations with probe
and polymer, respectively, and reaction developed with Romulin
3-amino-9-ethylcarbazole (AEC) chromogen (Scytek) prior to
being counterstained with 1:10 hematoxylin for 1min followed
by distilled water. Slides were air dried and cover slips then
applied with permanent synthetic mounting media.
For identification of CD3+ (T-cells) in lung parenchyma,
following deparaffinization and rehydration, tissue sections
underwent heat induced epitope retrieval with Citrate Plus
Retrieval pH 6.0 (Scytek) for 30min at 100◦C followed by a
10min incubation at RT. Endogenous peroxidase was blocked
as described above, and non-specific binding was blocked with
Rodent Block M for 10min. After pretreatments, 1:250 rabbit
anti-CD3 polyclonal antibody (Abcam, Cambridge, MA; catalog
#ab5690) was incubated for 1 h to identify T-cells. Bound
CD3 antibody was detected with ProMark Rat-on- Mouse
HRP polymer (Biocare) with 15min incubation for probe and
polymer, respectively and reaction developed with AEC for 5min
prior to being counterstained with hematoxylin.
For detection of IgG+ cells in lung, deparaffinized sections
were incubated with 0.03% pronase E for 10min at 37◦C
to achieve antigen retrieval and then endogenous peroxidase
inactivated as described above. After blocking for non-specific
protein with Rodent Block M (Biocare) sections were incubated
with 1:100 polyclonal goat anti-IgG (Bethyl Labs, Montgomery,
TX; catalog# A-90-100A) for 30min. Goat-specific Micro-
Polymer (Biocare) reagents were subsequently applied as per
manufacturer’s instructions, followed by reaction development
with Romulin AECTM (Biocare) and counterstained with
hematoxylin.
Immunohistochemistry for CD21+/CD35+ (FDC) was
performed on snap frozen cranial lobe of the right lung. Tissues
were sectioned at 7µm and sections air dried overnight on 2%
3-aminopropyltriethoxysilane coated slides. Sections were fixed
with acetate and formalin for 10min at RT, and endogenous
peroxidase was blocked using 3% hydrogen peroxide in TBS for
30min. Blocking for non-specific binding was performed with
Rodent Block M (Biocare) for 5min. Follow pretreatments, 1:500
rat anti-CD21/35 monoclonal antibody (Becton Dickinson;
catalog # 553817) was incubated for 1 h to identify FDCs. Bound
CD21/CD35 antibody was detected with ProMark Rat-on-Mouse
HRP polymer (Biocare) with 15min incubation for probe and
polymer, respectively and reaction developed with AEC for 5min
prior to being counterstained with hematoxylin.
Morphometry
To quantitate immunohistochemically labeled cells in lungs
(CD45R+, CD3+, and CD21+/CD35+) and kidneys (CD45R+)
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indicative of ELS, tissue morphometry was performed as
described previously (52). Briefly, slides were digitized with a
VS110 Virtual Slide System (Olympus). The entire tissue was
selected as the region of interest and 20% of the sections were
captured by systematic random sampling with NewCast software
(Visiopharm, Hoersholm, Denmark) and a virtual magnification
of 20X. Percentages of CD45R+, CD3+, or CD21/CD35+ cells
were calculated by projecting a point grid over randomly sampled
images with the STEPanizer v 1.8 stereology tool (56) and tallying
the number of points falling onto positive staining or reference
tissue.
Statistics
All treatments consisted of 8 mice per group, and data are
presented as mean ± SEM. One mouse in the 5 wk CON/VEH
group died of unknown causes during the course of the
experiment; it did not show the typical signs of sickness
including loss of body weight before death. The Shapiro-Wilk
test was used to determine if data were distributed normally,
and the robust outlier (ROUT) test (Q = 1%) was used to
identify putative outliers. For data sets that met assumptions
for normality and equal variance, a two-way ANOVA was used
with treatment and time point as the experimental factors. For
data that were normally distributed but unequal in variance,
a log10 transformation was applied and the parametric two-
way ANOVA was performed. Then, for each time point, the
Sidak’s post-hoc test for multiple comparisons was used for the
following pairwise comparisons identified a priori: CON/VEH vs.
CON/cSiO2; CON/cSiO2 vs. Low DHA/cSiO2; and CON/cSiO2
vs. High DHA/cSiO2. For data obtained at a single time point, a
one-way ANOVAwas performed with the same post-hoc pairwise
comparisons. Because the vast majority of histopathology score
data were not normally distributed and not suitable for typical
data transformations, these data were analyzed using the
nonparametric Kruskal-Wallis ANOVA on ranks (either two-
way or one-way, depending on the data set) followed by Dunn’s
multiple comparisons tests for the pairwise tests outlined above.
A p value < 0.05 was considered statistically different for main
effects of treatment, time point or treatment x time point and for
the pairwise comparisons to the negative (CON/VEH) or positive
control (CON/cSiO2) for all study outcomes. Statistical analyses
were performed using GraphPad Prism v.7 (La Jolla, CA).
RESULTS
DHA Is Incorporated in Tissues at the
Expense of ARA
GLC analysis confirmed that projected FA content of
experimental diets (Table 1) was consistent with their final
compositions (Table 2). Erythrocytes were further analyzed
to ascertain how experimental diets influenced tissue FA
profiles (57). Consumption of DHA (C22:6 ω-3) resulted in
increased erythrocyte concentrations of this FA and concurrently
decreased ARA (C20:4 ω-6) at 1 wk PI (Table 3). Interestingly,
although DHA was the predominant ω-3 PUFA, EPA (C20:5
ω-3) accounted for 16 and 21 percent of total ω-PUFAs in
erythrocytes from mice fed the Low DHA and High DHA diets,
TABLE 2 | Fatty acid (FA) content of experimental diets.
CON Low DHA High DHA
C12:0 0.04 ± 0.00 0.62 ± 0.00 1.42 ± 0.07
C14:0 0.16 ± 0.01 1.79 ± 0.02 4.15 ± 0.21
C15:0 0.03 ± 0.00 0.02 ± 0.00 0.03 ± 0.00
C16:0 5.64 ± 0.04 6.82 ± 0.02 7.79 ± 0.02
C16:1 7 c/8 c 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00
C16:1 9 c 0.08 ± 0.00 0.41 ± 0.00 0.86 ± 0.03
C17:0 0.03 ± 0.00 0.04 ± 0.00 0.04 ± 0.00
C18:0 1.71 ± 0.01 1.56 ± 0.01 1.39 ± 0.02
C18:1 9 c 71.08 ± 0.13 62.40 ± 0.08 53.26 ± 0.50
C18:1 11 c 0.75 ± 0.02 0.65 ± 0.01 0.55 ± 0.01
C18:2 (ω-6) 19.17 ± 0.10 18.94 ± 0.01 15.08 ± 0.79
C20:0 0.31 ± 0.00 0.28 ± 0.00 0.24 ± 0.00
C18:3 (ω-3) 0.36 ± 0.01 0.37 ± 0.00 0.32 ± 0.01
C22:0 0.22 ± 0.00 0.21 ± 0.00 0.20 ± 0.00
C24:0 0.14 ± 0.00 0.13 ± 0.00 0.12 ± 0.01
C22:5 (ω-3) 0.00 ± 0.00 0.09 ± 0.00 0.20 ± 0.01
C22:6 (ω-3) 0.00 ± 0.00 5.40 ± 0.05a 14.20 ± 0.65b
∑
SFA 8.3 ± 0.1 11.5 ± 0.1 15.4 ± 0.1
∑
MUFA 71.9 ± 0.1 63.5 ± 0.1 54.7 ± 0.5
∑
PUFA (ω-3) 0.4 ± 0.01 5.9 ± 0.1 14.7 ± 0.7
∑
PUFA (ω-6) 19.2 ± 0.1 18.9 ± 0.0 15.1 ± 0.8
ω-6:ω-3 52.8 ± 1.3 3.2 ± 0.0 1.0 ± 0.1
Data shown are mean percent of total lipid in diet ± SEM or the ratio of ω-6 to ω-3 FAs
of three representative diets as determined by GLC.
a Equivalent to 3.9 g/kg DHA diet.
b Equivalent to 9.9 g/kg DHA diet.
respectively. FA content in erythrocytes at 1 wk PI (Table 3)
did not appreciably differ from that of the 5, 9, or 13 wk PI
(Supplementary Tables 1–3). This suggested that ω-3 PUFA
incorporation peaked within 6 wk of initiating DHA feeding and
remained stable throughout the course of the experiment.
DHA Consumption Suppresses
cSiO2-Induced Mononuclear Cell Elevation
in BALF
Total cell counts in BALF of cSiO2-exposed mice fed CON diet
were modestly increased at 1 and 5 wk PI compared to VEH-
treated mice fed CON diet (Figure 2). By 9 and 13 wk PI, cell
numbers in the CON/cSiO2 group were dramatically elevated.
Rank order of the inflammatory cell populations wasmacrophage
> neutrophils > lymphocytes with eosinophils being negligibly
affected. cSiO2-induced inflammatory cell recruitment in the
lung alveolar space was suppressed significantly at 9 and 13 wk PI
in mice consuming the LowDHA andHigh DHA diets (Figure 2,
Supplementary Table 5).
DHA Supplementation Blocks
cSiO2-Induced Inflammation and Cell
Infiltration in Lung
At 1 and 5 wk PI, small lesions were evident in the lungs
of the CON/cSiO2 group as compared to CON/VEH group
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C14:0 0.15 ± 0.01 0.15 ± 0.01 0.23 ± 0.03 0.29 ± 0.03
C16:0 24.79 ± 0.43 24.70 ± 0.45 27.13 ± 0.54 29.11 ± 0.48
C16:1n7t 0.04 ± 0.01 0.04 ± 0.01 0.03 ± 0.01 0.03 ± 0.01
C16:1n7 0.59 ± 0.08 0.64 ± 0.03 0.61 ± 0.61 0.63 ± 0.10
C18:0 16.04 ± 0.42 15.87 ± 0.22 15.07 ± 0.32 14.30 ± 0.48
C18:1t 0.16 ± 0.01 0.16 ± 0.01 0.15 ± 0.01 0.14 ± 0.01
C18:1 ω-9 17.28 ± 0.51 17.19 ± 0.26 15.77 ± 0.54 15.01 ± 0.14
C18:2 ω-6t 0.06 ± 0.01 0.07 ± 0.01 0.05 ± 0.00 0.05 ± 0.00
C18:2 ω-6 9.35 ± 0.058 9.24 ± 0.51 11.71 ± 0.45 11.15 ± 0.75
C20:0 0.16 ± 0.02 0.14 ± 0.02 0.16 ± 0.02 0.15 ± 0.01
C18:3 ω-6 0.06 ± 0.02 0.07 ± 0.01 0.05 ± 0.01 0.03 ± 0.00
C20:1n9 0.43 ± 0.02 0.39 ± 0.02 0.30 ± 0.03 0.23 ± 0.02
C18:3 ω-3 0.04 ± 0.00 0.04 ± 0.00 0.05 ± 0.01 0.04 ± 0.01
C20:2 ω-6 0.27 ± 0.02 0.27 ± 0.01 0.25 ± 0.03 0.17 ± 0.01
C22:0 0.12 ± 0.01 0.11 ± 0.03 0.13 ± 0.03 0.13 ± 0.02
C20:3 ω-6 1.36 ± 0.10 1.43 ± 0.07 1.35 ± 0.16 0.80 ± 0.06
C20:4 ω-6 19.56 ± 0.89 19.97 ± 0.56 8.46 ± 0.50 3.90 ± 0.22
C24:0 0.21 ± 0.03 0.22 ± 0.05 0.25 ± 0.05 0.29 ± 0.05
C20:5 ω-3 0.24 ± 0.04 0.30 ± 0.03 2.75 ± 0.33 4.80 ± 0.26
C24:1 ω-9 0.24 ± 0.04 0.23 ± 0.06 0.24 ± 0.05 0.23 ± 0.04
C22:4 ω-6 1.98 ± 0.15 1.88 ± 0.06 0.38 ± 0.04 0.16 ± 0.02
C22:5 ω-6 0.68 ± 0.04 0.65 ± 0.04 0.09 ± 0.02 0.05 ± 0.01
C22:5 ω-3 0.58 ± 0.05 0.61 ± 0.03 0.94 ± 0.04 0.91 ± 0.05
C22:6 ω-3 5.59 ± 0.36 5.62 ± 0.20 13.85 ± 0.42 17.40 ± 0.64
∑
SFA 41.47 ± 0.49 41.19 ± 0.44 42.97 ± 0.46 44.26 ± 0.53
∑
MUFA 18.74 ± 0.49 18.66 ± 0.26 17.10 ± 0.63 16.27 ± 0.15
∑
PUFA (ω-3) 6.45 ± 0.44 6.57 ± 0.21 17.58 ± 0.58 23.15 ± 0.84
∑
PUFA (ω-6) 33.34 ± 0.51 33.58 ± 0.41 22.35 ± 0.84 16.32 ± 0.82
Analysis of experimental groups from 1 wk after final cSiO2 instillation. Data shown are
mean percent of total FA ± SEM (n = 8 per group) as determined by GLC. Data for 5, 9,
and 13 wk PI can be found in Supplementary Tables 1–3, respectively.
(Figure 3A, Table 4). Lymphoid aggregates in interstitial tissue
circumventing the airways and blood vessels were present in
some cSiO2-treated mice; mild alveolar proteinosis and alveolitis
were similarly apparent. By 9 wk PI, pulmonary lesions in
the CON/cSiO2 group were more severe (Figure 3C, Table 4,
Supplementary Table 4). ELS formation closely paralleled
increases in lymphoid aggregates in CON/cSiO2 mice. These
features were predominately present as interstitial lymphocytic
infiltrates encompassing the airways and blood vessels in the
lungs. Consumption of the High DHA diet diminished the size
of these lymphocytic lesions at 9 wk PI but did not appreciably
impact development of alveolar proteinosis or type II alveolar
epithelial cell hyperplasia.
Consistent with previous findings (35, 52), cSiO2 triggered
severe inflammation and ELS expansion at 13 wk PI
(Figures 3B,E, Table 4). In addition, mucous cell metaplasia in
the respiratory epithelium lining large-diameter bronchioles was
observed that was not evident at earlier time points. Attenuation
of lymphocyte-dependent lesions (i.e., lymphoid aggregates and
ELS) was evident in both the Low DHA and High DHA groups
(Figures 3D,F, Table 4, Supplementary Table 4). Consumption
FIGURE 2 | DHA supplementation suppresses cSiO2-induced elevation of
inflammatory cells in BALF. Total cell counts in BALF samples from NZBWF1
mice were conducted using a hemocytometer and then
monocytes/macrophages, lymphocytes, neutrophils, and eosinophils
quantified after differential staining using morphological criteria. Abbreviations:
C, control diet; L, Low DHA diet; H, High DHA diet. Data are means ± SEM
(n = 7–8 per group). Symbols: * indicates significantly different from CON/VEH
group (p < 0.05); # indicates significantly different from CON/cSiO2 group (p <
0.05). Complete statistical analyses can be found in Supplementary Table 5.
of the High DHA diet reduced cSiO2-induced alveolitis at
this time point, but this response was not evident in mice fed
the Low DHA diet. However, DHA did not markedly impact
cSiO2-induced lymphocyte-independent histopathological
lesions including alveolar proteinosis, type II alveolar epithelial
cell hyperplasia, and mucous cell metaplasia.
Dietary DHA Delays cSiO2-Induced
Accumulation of B- and T-Cell Aggregates
in Lung Over Time
Morphometry was used on immunohistochemically stained
slides from the lung to (1) quantify changes in B- and T-cells
during cSiO2-induced pulmonary ectopic lymphoid neogenesis
and (2) assess DHA’s influence on these lymphocyte populations
over time. cSiO2 elicited early and sustained CD45R
+ B-cell
and CD3+ T-cell elevation in lungs of mice fed CON diet
at 1 and 5 wk PI (Figures 4A,G, 5A,G). B- and T- cells
occurred mostly within diffuse interstitial infiltrates and did not
appear to organize into distinct ELS at these time points. By
9 wk PI, cSiO2 instillation caused pronounced formation of
focal B-cell aggregates interspersed with more diffuse T-cells in
CON-fed mice, thus resembling ELS with functional germinal
centers (Figures 4C,G, 5C,G). ELS in CON/cSiO2 group were
dramatically expanded by 13 wk PI (Figures 4E,G, 5E,G)
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FIGURE 3 | DHA consumption prevents cSiO2-triggered inflammation in lungs of NZBWF1 mice. Representative light photomicrographs depict H&E-stained lung
sections from CON/cSiO2 groups at (A) 5 wk post-instillation (PI), (C) 9 wk PI, and (E) 13 wk PI; (B) CON/VEH at 13 wk PI; (D) Low DHA/cSiO2 at 13 wk PI; and (F)
High DHA/cSiO2 at 13 wk PI. Black arrows in photomicrographs indicate lymphoid cell infiltration in the peribronchiolar and perivasculature interstitium. Dietary DHA
substantially suppressed lymphocytic infiltration (D, F; See also Table 4). Abbreviations: a, alveolar parenchyma; b, bronchiolar airway; v, blood vessel.
compared to VEH-treated mice fed control diet (Figures 4B,
5B). Notably, consumption of either Low DHA and High DHA
diets was markedly effective at restricting cSiO2-induced B-
and T-cell accumulation across all experimental time points




Immunohistochemistry for CD21+/CD35+ was used to quantify
FDCs, markers of germinal centers, in ELS of CON/cSiO2
mice. FDC numbers were not affected by cSiO2 in lung
sections from 1 or 5 wk PI (Figures 6A,G). However, by 9
and 13 wk PI, there was marked infiltration and networking
of FDCs in CON/cSiO2 groups (Figures 6C,E,G) compared
to corresponding CON/VEH mice (Figures 6B,G). FDCs were
found predominately in the perivascular and peribronchial
regions, which was consistent with the location of CD45R+
and CD3+ cell infiltrates. Remarkably, cSiO2-induced FDC
accumulation was nearly completely ablated in mice consuming
either DHA diets (Figures 6D,F,G, Supplementary Table 5). In
concert with FDC findings, large aggregates (Figure 7B) of
IgG+ plasma cells were present in the pulmonary perivascular
and peribronchiolar interstitial tissue and were associated with
ectopic lymphoid structures in CON/cSiO2 mice at wk 13. These
were significantly diminished in the mice fed low and high
DHA diets (Figures 7C,D,E). IgG+ plasma cells were few and
widely scattered in these regions of lung in CON/VEH mice
(Figures 7A,E). Accordingly, cSiO2 exposure elicited ectopic
lymphoid germinal center development, but this response was
blocked by inclusion of DHA in the diet.
DHA Suppresses Induction of Plasma
Anti-dsDNA Autoantibodies by cSiO2
Robust anti-dsDNA IgG responses were observed in BALF
(Figure 7F) and plasma (Figure 8, Supplementary Table 5) of
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TABLE 4 | Histopathological assessment of cSiO2-triggered pulmonary
inflammation in female NZBWF1 mice fed CON or DHA-enriched diets at 1, 5, 9,











1 0.6 ± 0.2 1.1 ± 0.1 0.9 ± 0.1 0.8 ± 0.2
5 0.6 ± 0.2 1.5 ± 0.2* 1.1 ± 0.1 0.8 ± 0.1
9 1.0 ± 0.0 3.1 ± 0.2* 2.2 ± 0.1 1.1 ± 0.2#
13 0.9 ± 0.1 3.6 ± 0.2* 2.0 ± 0.2# 1.6 ± 0.2#
Ectopic lymphoid
structures
1 0.0 ± 0.0 0.2 ± 0.2 0.0 ± 0.0 0.0 ± 0.0
5 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0
9 0.4 ± 0.0 2.4 ± 0.2* 1.2 ± 0.2 0.6 ± 0.2#
13 0.0 ± 0.0 3.4 ± 0.2* 1.6 ± 0.3 1.1 ± 0.3#
Alveolar
proteinosis
1 0.0 ± 0.0 1.5 ± 0.3* 1.1 ± 0.1 1.0 ± 0.0
5 0.0 ± 0.0 2.2 ± 0.2* 2.2 ± 0.2 2.1 ± 0.1
9 0.0 ± 0.0 4.0 ± 0.2* 4.0 ± 0.0 4.0 ± 0.0
13 0.0 ± 0.0 4.0 ± 0.1* 4.1 ± 0.1 4.1 ± 0.1
Alveolitis 1 0.0 ± 0.0 1.0 ± 0.0* 1.0 ± 0.0 0.4 ± 0.1#
5 0.0 ± 0.0 1.2 ± 0.2* 1.0 ± 0.0 1.0 ± 0.0
9 0.0 ± 0.0 2.6 ± 0.3* 1.9 ± 0.2 1.1 ± 0.2#




1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
5 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
9 0.0 ± 0.0 0.6 ± 0.2* 0.6 ± 0.2 0.6 ± 0.2
13 0.0 ± 0.0 2.2 ± 0.2* 1.6 ± 0.3 1.6 ± 0.3
Mucous cell
metaplasia
1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
5 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
9 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
13 0.0 ± 0.0 2.2 ± 0.2 0.4 ± 0.2 0.1 ± 0.1
NZBWF1 mice (n = 7–8/group) were graded individually for severity of lung inflammation
(% of total pulmonary tissue) as follows: 0, no changes; 1, minimal (<10%); 2, slight (10–
25%); 3, moderate (26–50%); 4, severe (51–75%); 5, very severe (> 75%) of total area
affected. Data are shown as mean ± SEM score for each pathological lesion. *indicates
treatment group is significantly different compared to CON/VEH (p < 0.05). # indicates
treatment group is significantly different compared to CON/cSiO2 (p < 0.05). Complete
statistical results are provided in Supplementary Table 4.
cSiO2-instilled mice fed CON diet at 9 and 13 week PI compared
to VEH-treated mice fed CON diet. Consumption of DHA
suppressed these autoantibody responses. Thus, cSiO2-induced
anti-dsDNA IgG responses in BALF and plasma and their
suppression by DHA recapitulated the impact of these agents on
ectopic germinal center development in the lung.
Dietary DHA Diminishes cSiO2-Induced
Glomerulonephritis and B-Cell Infiltration
in the Kidney
Kidneys were evaluated histologically for glomerulonephritis
over the entire experimental time course. Significant lesions
were apparent only at 13 wk PI with nephritis being detectable
FIGURE 4 | DHA consumption delays cSiO2-triggered B-cell appearance in
lungs of NZBWF1 mice. Pulmonary densities of immunohistochemically
labeled B-cells (CD45R+) in hematoxylin counterstained lung sections were
immunohistochemically and morphometrically determined as described in
Materials and Methods. Representative photomicrographs depict CD45R+
cells (reddish brown chromogen, indicated by arrows) in (A) CON/cSiO2 at 5
wk post-instillation (PI), (C) 9 wk PI, and (E) 13 wk PI; (B) CON/VEH at 13 wk
PI; (D) Low DHA/cSiO2 at 13 wk PI; and (F) High DHA/cSiO2 at 13 wk PI.
Abbreviations: a, alveolar parenchyma; b, bronchiolar airway; v, blood vessel.
(G) Volume densities of CD45R+ cells are graphically expressed as means +
SEM (n = 7–8 per group). Symbols: * indicates significantly different from
CON/VEH group (p < 0.05); # indicates significantly different from CON/cSiO2
group (p < 0.05). Complete statistical analyses can be found in
Supplementary Table 5.
in 0, 5, 1, or 0 mice per group (n = 8) in the CON/VEH,
CON/cSiO2, Low DHA/cSiO2, or High DHA/cSiO2 groups,
respectively (Figures 9A–D). Tubular proteinosis was evident at
13 wk PI in the CON/cSiO2 group but not in the CON/VEH, Low
DHA/cSiO2, or High DHA/cSiO2 groups (Figure 9E).
B-cell infiltrates in the kidney have been previously associated
with severity of lupus nephritis (58–60). Marked cell infiltration
was evident in kidney tissues of mice in the CON/cSiO2
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FIGURE 5 | DHA consumption delays cSiO2-triggered T-cell appearance in
lungs of NZBWF1 mice. Pulmonary densities of immunohistochemically
labeled T-cells (CD3+), in hematoxylin counterstained lung sections were
morphometrically determined as described in Materials and Methods.
Representative photomicrographs depict CD3+ cells (reddish brown
chromogen, indicated by arrows) in (A) CON/cSiO2 at 5 wk post-instillation
(PI), (C) 9 wk PI, and (E) 13 wk PI; (B) CON/VEH at 13 wk PI; (D) Low
DHA/cSiO2 at 13 wk PI; and (F) High DHA/cSiO2 at 13 wk PI. Abbreviations:
a, alveolar parenchyma; b, bronchiolar airway; v, blood vessel. (G) Volume
densities of CD3+ cells are graphically expressed as means + SEM (n = 7–8
per group). Symbols: * indicates significantly different from CON/VEH group (p
< 0.05); # indicates significantly different from CON/cSiO2 group (p < 0.05).
Complete statistical analyses can be found in Supplementary Table 5.
group at 13 wk PI compared to the other experimental
groups. (Figures 10A–D). Immunohistochemistry revealed that
in CON/cSiO2 mice kidneys, CD45R
+ cells localized into
distinct, focal aggregates in the interstitium surrounding
interlobular arteries and veins in the renal cortex and near the
renal pelvis (Figures 10E,F). A trend toward reduced cSiO2-
triggered B-cell accumulation was evident in mice fed DHA
(Figures 10G,H,I). Given that cSiO2 particles in this study are
too large to diffuse into systemic circulation via the lung and are
FIGURE 6 | DHA consumption delays cSiO2-triggered follicular dendritic cell
networking in lungs of NZBWF1 mice. Pulmonary densities of
immunohistochemically labeled follicular dendritic cell (CD21/35+) networking
in hematoxylin counterstained lung sections were morphometrically
determined as described in Materials and Methods. Representative
photomicrographs depict CD21/35+cells (reddish brown chromogen,
indicated by arrows) in (A) CON/cSiO2 at 5 wk post-instillation (PI), (C) 9 wk
PI, and (E) 13 wk PI; (B) CON/VEH at 13 wk PI; (D) Low DHA/cSiO2 at 13 wk
PI; and (F) High DHA/cSiO2 at 13 wk PI. Abbreviations: a, alveolar
parenchyma; v, blood vessel. (G) Volume densities of CD21/35+ cells are
graphically expressed as means + SEM (n = 7–8 per group). Symbols: *
indicates significantly different from CON/VEH group (p < 0.05); # indicates
significantly different from CON/cSiO2 group (p < 0.05). Complete statistical
analyses can be found in Supplementary Table 5.
insoluble in water, it seems unlikely that these particles could be
deposited in tissues distal to the lung. We did not observe cSiO2
particles in kidney by birefringent microscopy (unpublished
observations) suggesting the improbability of direct deposition




Understanding how cSiO2 triggers autoimmunity in this
preclinical model is important not only because exposure to
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FIGURE 7 | Dietary DHA suppresses cSiO2-triggered plasma cell influx in lungs and elevation of anti-dsDNA IgG in bronchoalveolar lavage fluid of NZBWF1 mice at
13 wk post-instillation. (A–D) Light photomicrographs of lung sections, immunohistochemically stained for IgG (dark reddish brown chromagen), from mice in the
13-wk post-exposure groups – (A) CON/VEH, (B) CON/cSiO2, (C) Low DHA/cSiO2 and (D) High DHA/cSiO2 mice. A marked infiltration of IgG
+ plasma cells (arrows)
was present in interstitial tissue surrounding blood vessels (v) and bronchiolar airways (BA) in the lungs of CON/cSiO2 mice (B). Extracellular IgG was also
conspicuous in alveolar airspaces (a) of these mice. Densities of IgG+ plasma cells and alveolar extracellular IgG were strikingly less in the lungs of both Low
DHA/cSiO2 and High DHA/cSiO2 mice (C and D, respectively). Only a few widely scattered IgG
+ plasma cells were occasionally present in the peribronchiolar and
perivascular interstitial tissue of CON/VEH mice (A). (E) Morphometrically determined volume densities of IgG+ plasma cells are graphically expressed as means +
SEM (n = 7–8 per group). Symbols: * indicates significantly different from CON/VEH group (p < 0.05); # indicates significantly different from CON/cSiO2 group (p <
0.05). (F) Dietary DHA suppresses cSiO2 -induced elevation of anti-dsDNA IgG in bronchiolar lavage fluid (BALF). BALF was pooled for each experimental group and
analyzed in duplicate. Data represent means ± SEM. * indicates significantly different from CON/VEH group (p < 0.05).
this respirable particle has been linked to human autoimmune
disease but also because this response serves as a model for
agents that cause sterile inflammation. Inhalation of cSiO2
elicits a cascade that includes: (1) phagocytosis by alveolar
macrophages, (2) lysosomal membrane permeabilization, (3)
inflammasome activation, (4) release of inflammatory mediators,
and (5) cell death and release of free cSiO2 particles (61–
68). Since cSiO2 clearance from the lung is minimal (69),
persistent repetition of this cascade evokes buildup of cell
corpses, secondary necrosis, alarmin release, and self-antigen
presentation that very likely culminate in early loss of
tolerance and autoimmunity. Consistent with this scenario,
we report here for the first time that cSiO2 instillation
sequentially induces the accumulation of pulmonary B- and T-
cell aggregates (1, 5 wk PI) → FDC networking and plasma
cell accumulation in lung indicative of ectopic lymphoid
germinal centers (9, 13 wk PI) → BALF and plasma anti-
dsDNA IgG elevation (9, 13 wk PI) → glomerulonephritis
with B-cell accumulation (13 wk PI). These observations
provide unique insight into how respirable cSiO2 might induce
initiation and potentially flaring in lupus and other human
ADs.
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FIGURE 8 | Dietary DHA suppresses cSiO2 -induced elevation anti-dsDNA
IgG in plasma of NZBWF1 mice. Anti-dsDNA IgG in plasma of NZBWF1 mice
was quantitated by ELISA. Data are means ± SEM (n = 7–8 per group).
Symbols: * indicates significantly different from CON/VEH group (p < 0.05); #
indicates significantly different from CON/cSiO2 group (p < 0.05). Complete
statistical analyses can be found in Supplementary Table 5.
While our data suggest that the lung is likely to be a
rich source of anti-dsDNA antibodies in the plasma, it is
also possible that these could also originate at other sites
such as the spleen as a result of lymphocyte homing from
the lung or stimulation of new germinal centers by IgG-
immune complexes arising from the lung. However, we did
not detect histological differences in splenic architecture in the
13 wk cohort that would be suggestive of changes in germinal
center development between CON/VEH and CON/cSiO2 mice
(data not shown).
Managing lupus involves reducing disease symptoms in
newly diagnosed individuals and preventing progression
of established tissue damage to organs such as kidney
(70). Existing and emerging lupus therapies have multiple
mechanisms of action, broadly encompassing non-specific
immunosuppression, lymphocyte depletion, and neutralization
of immune-stimulating cytokines and chemokines (70–73).
These approaches have serious limitations including serious
adverse effects, inability to reverse immune-mediated damage,
and high costs (70, 74). Significantly, several studies have
indicated that ELS function as a survival niches, potentially
shielding autoreactive plasma cells from immunosuppressive
therapies (75–77). Therefore, strategies are needed to block
ELS development and limit their capacity to exacerbate lupus
progression and severity.
Consumption of ω-3 PUFAs such as DHA represents
an alternative and/or complementary approach to mitigate
autoimmune disease and other chronic health conditions.
Omega-3 PUFAs are the most widely consumed nutritional
supplement after multivitamins, taken by∼30million Americans
(78, 79). Dietary ω-3 PUFA incorporation occurs in tissues
and cells throughout the body, including immune cells. In
general, ω-3 PUFAs are considered anti-inflammatory and
FIGURE 9 | cSiO2 induced tubular proteinosis in kidneys of NZBWF1 mice at
13 wk PI. Light photomicrographs of kidney sections from NZBWF1 mice at
13 wk PI that were histochemically stained with Periodic acid-Schiff and
hematoxylin (PASH) and morphometrically analyzed for tubular proteinosis.
Significant lesions were detectable in 0/8, 5/8, 1/8, and 0/8 mice in the
CON/VEH, CON/cSiO2, Low DHA/cSiO2, and High DHA/cSiO2 groups,
respectively. Representative photomicrographs of the renal cortex in (A)
CON/VEH; (B) CON/cSiO2; (C) Low DHA/cSiO2; and (D) CON/VEH at 13 wk
PI; and (D) High DHA/cSiO2. Abbreviations: g, glomerulus; rt, renal tubules; *,
tubular protein; arrows, sclerotic glomerulus. (E) Morphometric assessment of
tubular proteinosis. Data are means ± SEM (n = 8 per group). Symbol: *
indicates significant difference (p < 0.05) between CON/VEH and CON/cSiO2.
Complete statistical analyses can be found in Supplementary Table 6.
promote resolution of inflammation, whereas ω-6 PUFAs are
considered proinflammatory. Using FA content of erythrocytes,
an established predictor of PUFA levels of other tissues in
the body (57), we found here that dietary supplementation
with DHA promoted incorporation of both DHA and another
ω-3 PUFA, EPA, at the expense of the ω-6 PUFA ARA.
Since the EPA content of the DHA diets was negligible,
our findings suggest that there was enzymatic retroconversion
of DHA to EPA as has been reported previously in mice
fed DHA (80). A highly likely effect of increased ω-3
PUFA tissue content is skewing of immune cells toward less
inflammatory phenotypes that dampen chronic inflammation
and autoimmunity (81). In support of that contention, we
show here that dietary DHA supplementation, at levels that
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mimic realistic human consumption, blocked or delayed (1)
pulmonary B-cell, T-cell, and FDC networking; (2) plasma
autoantibody increases; and (3) glomerulonephritis and B-cell
infiltration in the kidneys of cSiO2-treated mice. Accordingly,
our findings are consistent with the possibility that ω-
3 PUFA supplementation might be practical strategy to
intervene against an established environmental trigger of
autoimmunity.
DHA and its retroconversion product EPA potentially
quell cSiO2-triggered autoimmunity by altering bioactive lipid
mediator production, intracellular signaling, transcription
factor activity, gene expression, and membrane structure and
function [reviewed in (40)]. Relative to bioactive lipid mediators,
eicosanoids are a diverse category of metabolites that collectively
include lipoxins, prostaglandins, and thromboxanes; these
metabolites can influence both progression and resolution
of inflammation. Eicosanoids are known to be induced in
macrophages by cSiO2 (82–86) and are associated with human
lupus. These bioregulators are derived from metabolism of
free (non-esterified) FAs that are liberated from the plasma
membrane by activated phospholipase A2 (PLA2). The free
FAs serve as substrates for cyclooxygenase, lipoxygenase,
or cytochrome P450 enzymes. Competition for these
enzymes by liberated PUFAs results in different metabolite
signatures that can potentiate or attenuate inflammation.
Generally, metabolites derived from ω-6s like LA and ARA
are considered proinflammatory, whereas ω-3s produce
specialized pro-resolving metabolites (SPMs) that enhance
resolution of tissue inflammation (87). DHA-derived SPMs
include the D-series resolvins, protectins, and maresins. Of
special relevance to the cSiO2 model, DHA and its SPMs
have been shown to suppress inflammasome activation,
prevent cell death, and enhance removal of cell corpses
by efferocytosis (88–91). Toward this end, we are now
focusing on how DHA and/or its SPMs influence alveolar
macrophages responses to cSiO2 and how these events shape
autoimmunity.
Taken together, the results presented herein demonstrate that
cSiO2 instillation in a lupus-prone mouse model sequentially
induced de novo ectopic lymphoid germinal center formation
in the lung (depicted in Figure 11), systemic autoantibody
elevation, and glomerulonephritis. Furthermore, all of these
responses were inhibited by inclusion of DHA in the diet.
Upon considering the potential adverse outcomes of DHA and
other ω-3 PUFAs, including those related to immune function,
an expert committee of the European Food Safety Authority
concluded that human intake up to 5 g/day is safe (92).
Thus, the amounts of DHA used in this preclinical study,
equivalent to 2 and 5 g/day human consumption, are consistent
with realistic and safe doses in a clinical setting. Relative
to human lupus, DHA supplementation may potentially aid
two broad groups. One group is patients that are diagnosed
with early-stage lupus where it could be used as a low-cost
treatment, alone or as a complimentary approach to existing
therapies. The second is individuals at increased risk for lupus
who would benefit from a preventative measure with minimal
side effects. This latter group could include asymptomatic
FIGURE 10 | Lymphocytic and B-cell accumulation in kidneys of NZBWF1
mice 13 wk following cSiO2 exposure are prevented by dietary
supplementation with DHA. Renal densities of lymphocyte and B-cell
(CD45R+) were determined by routine light microscopic examination (H&E
stained sections) and immunohistochemistry, respectively, as described in
Materials and Methods. Representative light photomicrographs of H&E stained
kidney sections depict (A) CON/VEH, (B) CON/cSiO2, (C) Low DHA/cSiO2;
and (D) High DHA/cSiO2 at 13 wk PI. Light photomicrographs of CD45R
+
cells (reddish brown chromogen, indicated by arrows) in lung sections from (E)
CON/VEH, (F) CON/cSiO2, (G) Low DHA/cSiO2; and (H) High DHA/cSiO2 at
13 wk PI; and (F) High DHA/cSiO2 at 13 wk PI. Abbreviations: rc, renal cortex;
rm, renal medulla; ia, intralobular artery; iv, intralobular vein. Asterisk indicates
focal aggregates in the interstitium. (I) Volume densities of CD45R+ cells are
graphically expressed as means ± SEM (n = 8 per group). No significant
differences were identified for comparisons to CON/VEH or CON/cSiO2.
Complete statistical analyses can be found in Supplementary Table 6.
individuals who have a close family member with lupus or
workers occupationally exposed to respirable silica or related
particles. Future preclinical studies using the cSiO2-triggered
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FIGURE 11 | Temporal profile of cSiO2-triggered ectopic germinal center formation in the lung. Diagrammatic representation of lymphoid cell infiltration and
development of ectopic lymphoid structures with germinal centers in the interstitial tissue surrounding a bronchiolar airway and adjacent blood vessel (A) prior to
cSiO2 exposure, (B) at 1 and 5 wk PI, and (C) at 9 and 13 wk PI. Small accumulations of lymphoid cells are present in the perivascular and airway interstitial tissue at
1 wk PI with increasing numbers of lymphocytes (mainly B-cells) in the interstitial tissue at 5 wk PI. Distinct ectopic lymphoid structures characterized by follicular
dendritic cell-laden germinal centers and numerous plasma cells were present by 9 and 13 wk after the final cSiO2 exposure.
lupus-prone mouse models should focus on assessing the
potential of DHA to serve as a therapeutic against established
lupus and comparing the efficacy of DHA to established
immunosuppressive agents used as the standard of care for
individuals.
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